What is Alembic Pharmaceuticals Price-to-Operating-Cash-Flow?
As of today (2024-05-28), Alembic Pharmaceuticals's share price is ₹946.30.
Alembic Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:
BOM:533573'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 0 Max: 47.31
Current: 23.24
During the past 13 years, Alembic Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 47.31. The lowest was 0.00. And the median was 0.00.
Alembic Pharmaceuticals's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ₹0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Alembic Pharmaceuticals was 10.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -18.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 0.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 12.80% per year.
During the past 13 years, Alembic Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 65.80% per year. The lowest was -18.50% per year. And the median was 11.00% per year.
Alembic Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alembic Pharmaceuticals Price-to-Operating-Cash-Flow Chart
|
Alembic Pharmaceuticals Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
22.40 |
12.78 |
26.38 |
13.46 |
24.04 |
|
Alembic Pharmaceuticals Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
13.46 |
- |
- |
- |
24.04 |
Competitive Comparison of Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.
Alembic Pharmaceuticals Price-to-Operating-Cash-Flow Calculation
Alembic Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 946.30 | / | 0 |
| = | |
Alembic Pharmaceuticals's Share Price of today is ₹946.30.
Alembic Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Alembic Pharmaceuticals (BOM:533573) Business Description
Traded in Other Exchanges
Address
Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Alembic Pharmaceuticals (BOM:533573) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:533573 has been successfully added to your